Published in PLoS Comput Biol on January 17, 2013
Epidemiology of human African trypanosomiasis. Clin Epidemiol (2014) 1.45
Modeling infectious disease dynamics in the complex landscape of global health. Science (2015) 1.37
Is vector control needed to eliminate gambiense human African trypanosomiasis? Front Cell Infect Microbiol (2013) 1.23
Mosquito vector diversity across habitats in central Thailand endemic for dengue and other arthropod-borne diseases. PLoS Negl Trop Dis (2013) 1.04
Glossina fuscipes populations provide insights for human African trypanosomiasis transmission in Uganda. Trends Parasitol (2013) 1.01
Tsetse Control and Gambian Sleeping Sickness; Implications for Control Strategy. PLoS Negl Trop Dis (2015) 0.99
Treating cattle to protect people? Impact of footbath insecticide treatment on tsetse density in Chad. PLoS One (2013) 0.97
Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo. Parasit Vectors (2015) 0.92
A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness"). PLoS Negl Trop Dis (2015) 0.90
Domestic pigs as potential reservoirs of human and animal trypanosomiasis in Northern Tanzania. Parasit Vectors (2013) 0.90
One health - an ecological and evolutionary framework for tackling Neglected Zoonotic Diseases. Evol Appl (2016) 0.88
Eight challenges in modelling disease ecology in multi-host, multi-agent systems. Epidemics (2014) 0.87
Implications of Heterogeneous Biting Exposure and Animal Hosts on Trypanosomiasis brucei gambiense Transmission and Control. PLoS Comput Biol (2015) 0.86
Evaluating long-term effectiveness of sleeping sickness control measures in Guinea. Parasit Vectors (2015) 0.85
Kinases as Druggable Targets in Trypanosomatid Protozoan Parasites. Chem Rev (2014) 0.83
Detecting differential transmissibilities that affect the size of self-limited outbreaks. PLoS Pathog (2014) 0.82
Null expectations for disease dynamics in shrinking habitat: dilution or amplification? Philos Trans R Soc Lond B Biol Sci (2017) 0.82
The consequences of reservoir host eradication on disease epidemiology in animal communities. Emerg Microbes Infect (2016) 0.80
Learning and Memory in Disease Vector Insects. Trends Parasitol (2016) 0.77
Revisiting zoonotic human African trypanosomiasis control in Uganda. J Public Health Policy (2015) 0.77
Trypanosoma brucei gambiense Infections in Mice Lead to Tropism to the Reproductive Organs, and Horizontal and Vertical Transmission. PLoS Negl Trop Dis (2016) 0.76
Who acquires infection from whom and how? Disentangling multi-host and multi-mode transmission dynamics in the 'elimination' era. Philos Trans R Soc Lond B Biol Sci (2017) 0.75
Xenomonitoring of sleeping sickness transmission in Campo (Cameroon). Parasit Vectors (2016) 0.75
Forecasting Human African Trypanosomiasis Prevalences from Population Screening Data Using Continuous Time Models. PLoS Comput Biol (2016) 0.75
Simulating the elimination of sleeping sickness with an agent-based model. Parasite (2016) 0.75
Molecular evidence of a Trypanosoma brucei gambiense sylvatic cycle in the human african trypanosomiasis foci of Equatorial Guinea. Front Microbiol (2015) 0.75
Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med (2008) 6.70
Human African trypanosomiasis. Lancet (2009) 5.60
Identifying reservoirs of infection: a conceptual and practical challenge. Emerg Infect Dis (2002) 4.79
Epidemic dynamics at the human-animal interface. Science (2009) 3.79
The construction of next-generation matrices for compartmental epidemic models. J R Soc Interface (2009) 2.68
Identification of human-infective trypanosomes in animal reservoir of sleeping sickness in Uganda by means of serum-resistance-associated (SRA) gene. Lancet (2001) 2.36
The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo. Trop Med Int Health (2004) 1.89
A general model for the African trypanosomiases. Parasitology (1988) 1.65
Wild fauna as a probable animal reservoir for Trypanosoma brucei gambiense in Cameroon. Infect Genet Evol (2005) 1.59
African trypanosomiasis. Ann Trop Med Parasitol (2006) 1.55
Epidemiological studies on the animal reservoir of Gambiense sleeping sickness. Part III. Characterization of trypanozoon stocks by isoenzymes and sensitivity to human serum. Tropenmed Parasitol (1982) 1.45
The natural progression of Gambiense sleeping sickness: what is the evidence? PLoS Negl Trop Dis (2008) 1.31
Tripartite interactions between tsetse flies, Sodalis glossinidius and trypanosomes--an epidemiological approach in two historical human African trypanosomiasis foci in Cameroon. Infect Genet Evol (2009) 1.27
Tsetse fly host preference from sleeping sickness foci in Cameroon: epidemiological implications. Infect Genet Evol (2007) 1.25
The elimination of Trypanosoma brucei gambiense sleeping sickness in the focus of Luba, Bioko Island, Equatorial Guinea. Trop Med Int Health (2006) 1.10
Tsetse EP protein protects the fly midgut from trypanosome establishment. PLoS Pathog (2010) 1.09
Accuracy of five algorithms to diagnose gambiense human African trypanosomiasis. PLoS Negl Trop Dis (2011) 1.09
Learning influences host choice in tsetse. Biol Lett (2007) 1.09
How to find natural reservoir hosts from endemic prevalence in a multi-host population: a case study of influenza in waterfowl. Epidemics (2009) 1.08
New developments in human African trypanosomiasis. Curr Opin Infect Dis (2006) 1.07
Transmissibility of Trypanosoma brucei during its development in cattle. Trop Med Int Health (2005) 1.07
Tracking the feeding patterns of tsetse flies (Glossina genus) by analysis of bloodmeals using mitochondrial cytochromes genes. PLoS One (2011) 1.05
Domestic animals as potential reservoir hosts of Trypanosoma brucei gambiense in sleeping sickness foci in Cameroon. Parasite (2010) 1.05
Control strategies for sleeping sickness in Central Africa: a model-based approach. Trop Med Int Health (1996) 0.99
Predicting the effect of climate change on African trypanosomiasis: integrating epidemiology with parasite and vector biology. J R Soc Interface (2011) 0.98
Screening of Trypanosoma brucei gambiense in domestic livestock and tsetse flies from an insular endemic focus (Luba, Equatorial Guinea). PLoS Negl Trop Dis (2010) 0.97
A global sensitivity analysis for African sleeping sickness. Parasitology (2010) 0.94
Spatial and temporal patterns of human African trypanosomosis (HAT) transmission risk in the Bipindi focus, in the forest zone of southern Cameroon. Vector Borne Zoonotic Dis (2004) 0.93
Persistence in seasonally forced epidemiological models. J Math Biol (2011) 0.93
[Risk factors for human African trypanosomiasis in the Bipindi region of Cameroon]. Med Trop (Mars) (2001) 0.92
Diversity and spatial distribution of vectors and hosts of T. brucei gambiense in forest zones of, Southern Cameroon: epidemiological implications. Acta Trop (2010) 0.85
Influence of habitat and seasonal variation on wild mammal diversity and distribution with special reference to the Trypanosoma brucei gambiense host-reservoir in Bipindi (Cameroon). Acta Trop (2009) 0.83
Observations on trypanosomiasis in the Belgian Congo. Trans R Soc Trop Med Hyg (1947) 0.83
[History of the onset and spread of sleeping sickness in Bipindi (southern Cameroon), from 1896 to today]. Med Trop (Mars) (2001) 0.82
[Animal reservoir of Trypanosoma (Trypanozoon) brucei gambiense in Central africa]. Ann Soc Belg Med Trop (1989) 0.78
Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24
Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med (2008) 13.35
Delaying the international spread of pandemic influenza. PLoS Med (2006) 4.50
Planning for smallpox outbreaks. Nature (2003) 4.16
Health-care needs of people affected by conflict: future trends and changing frameworks. Lancet (2010) 3.82
Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg (2004) 3.18
Interim smallpox guidelines for the United Kingdom. BMJ (2002) 3.14
Violence and mortality in West Darfur, Sudan (2003-04): epidemiological evidence from four surveys. Lancet (2004) 3.14
Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ (2008) 3.08
Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. J R Soc Interface (2007) 2.83
Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America. Influenza Other Respir Viruses (2009) 2.69
Dynamic social networks and the implications for the spread of infectious disease. J R Soc Interface (2008) 2.69
Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Vaccine (2010) 2.66
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Trop Med Int Health (2006) 2.39
Persistence of livestock associated MRSA CC398 in humans is dependent on intensity of animal contact. PLoS One (2011) 2.20
Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002-2003. Emerg Infect Dis (2004) 2.16
Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BMC Infect Dis (2010) 2.05
Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect Dis (2010) 2.01
Methicillin resistant Staphylococcus aureus ST398 in veal calf farming: human MRSA carriage related with animal antimicrobial usage and farm hygiene. PLoS One (2010) 1.98
Transmissibility of seasonal and pandemic influenza in a cohort of households in Hong Kong in 2009. Epidemiology (2011) 1.95
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe. Vaccine (2009) 1.94
Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact. Vaccine (2013) 1.94
Using time-use data to parameterize models for the spread of close-contact infectious diseases. Am J Epidemiol (2008) 1.92
Using an online survey of healthcare-seeking behaviour to estimate the magnitude and severity of the 2009 H1N1v influenza epidemic in England. BMC Infect Dis (2011) 1.89
Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet Neurol (2012) 1.85
Precautionary behavior in response to perceived threat of pandemic influenza. Emerg Infect Dis (2007) 1.84
Pre-emptive war epidemiology: lessons from the Democratic Republic of Congo. Lancet (2006) 1.83
Social contact patterns in Vietnam and implications for the control of infectious diseases. PLoS One (2011) 1.83
Cetyl-pyridinium chloride is useful for isolation of Mycobacterium tuberculosis from sputa subjected to long-term storage. J Clin Microbiol (2005) 1.82
Measured dynamic social contact patterns explain the spread of H1N1v influenza. PLoS Comput Biol (2012) 1.77
Infectious disease: tough choices to reduce Ebola transmission. Nature (2014) 1.77
Estimating the impact of childhood influenza vaccination programmes in England and Wales. Vaccine (2008) 1.76
Internet-based surveillance of Influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health (2010) 1.75
Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med (2013) 1.74
The burden of acute respiratory infections in crisis-affected populations: a systematic review. Confl Health (2010) 1.72
Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda. PLoS Clin Trials (2006) 1.72
Estimating the reproduction number of the novel influenza A virus (H1N1) in a Southern Hemisphere setting: preliminary estimate in New Zealand. N Z Med J (2009) 1.70
Deaths from norovirus among the elderly, England and Wales. Emerg Infect Dis (2008) 1.65
Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ (2002) 1.63
The burden of Herpes Zoster: a prospective population based study. Vaccine (2005) 1.61
Modeling cervical cancer prevention in developed countries. Vaccine (2008) 1.61
What types of contacts are important for the spread of infections?: using contact survey data to explore European mixing patterns. Epidemics (2011) 1.56
Aerosol transmission is an important mode of influenza A virus spread. Nat Commun (2013) 1.56
Evaluation of the benefits and risks of introducing Ebola community care centers, Sierra Leone. Emerg Infect Dis (2015) 1.56
Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. J Infect Dis (2012) 1.54
Surveillance of wild birds for avian influenza virus. Emerg Infect Dis (2010) 1.52
Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol (2005) 1.52
Death rates from malaria epidemics, Burundi and Ethiopia. Emerg Infect Dis (2007) 1.51
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg (2014) 1.51
The earliest notes on the reproduction number in relation to herd immunity: Theophil Lotz and smallpox vaccination. J Theor Biol (2006) 1.48
Infection fatality risk of the pandemic A(H1N1)2009 virus in Hong Kong. Am J Epidemiol (2013) 1.47
The state-reproduction number for a multistate class age structured epidemic system and its application to the asymptomatic transmission model. Math Biosci (2008) 1.44
Household transmission of 2009 pandemic influenza A (H1N1): a systematic review and meta-analysis. Epidemiology (2012) 1.43
Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe. Tuberculosis (Edinb) (2009) 1.43
Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo. Bull World Health Organ (2006) 1.43
The impact of school holidays on the social mixing patterns of school children. Epidemics (2011) 1.43
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. BMC Infect Dis (2010) 1.41
Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. J Clin Virol (2004) 1.41
The ideal reporting interval for an epidemic to objectively interpret the epidemiological time course. J R Soc Interface (2009) 1.39
The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect (2007) 1.39
The possible macroeconomic impact on the UK of an influenza pandemic. Health Econ (2010) 1.37
Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004. Antimicrob Agents Chemother (2006) 1.36
Mortality among displaced former UNITA members and their families in Angola: a retrospective cluster survey. BMJ (2003) 1.36
Cost-effectiveness analyses of human papillomavirus vaccination. Lancet Infect Dis (2007) 1.36
The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. Eur J Epidemiol (2004) 1.32
Users' guides to the medical literature: how to use an article about mortality in a humanitarian emergency. Confl Health (2008) 1.28
Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis (2012) 1.28
Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic. Proc Biol Sci (2011) 1.28
The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study. PLoS One (2011) 1.27
Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo. Bull World Health Organ (2006) 1.25
Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania. BMC Med (2012) 1.24
Integrated mapping of establishment risk for emerging vector-borne infections: a case study of canine leishmaniasis in southwest France. PLoS One (2011) 1.24
Estimating deaths due to influenza and respiratory syncytial virus. JAMA (2003) 1.23
The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination. PLoS One (2011) 1.23
Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. BMJ (2012) 1.23
The uncertain burden of Plasmodium falciparum epidemics in Africa. Trends Parasitol (2007) 1.22
Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations. Trans R Soc Trop Med Hyg (2005) 1.22
Developing a realistic sexual network model of chlamydia transmission in Britain. Theor Biol Med Model (2006) 1.22
Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine (2011) 1.21
Calibrating models in economic evaluation: a seven-step approach. Pharmacoeconomics (2011) 1.21
Public health surveillance after the 2010 haiti earthquake: the experience of médecins sans frontières. PLoS Curr (2013) 1.21
Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment. Trop Med Int Health (2008) 1.18
Age-specificity of clinical dengue during primary and secondary infections. PLoS Negl Trop Dis (2011) 1.18
Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone. Trop Med Int Health (2006) 1.18
Determinants of follow-up participation in the Internet-based European influenza surveillance platform Influenzanet. J Med Internet Res (2014) 1.16
Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic. Emerg Infect Dis (2008) 1.16
The effectiveness of contact tracing in emerging epidemics. PLoS One (2006) 1.15
The cost-effectiveness of syndromic management in pharmacies in Lima, Peru. Sex Transm Dis (2003) 1.15
Case fatality ratio of pandemic influenza. Lancet Infect Dis (2010) 1.14
Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan. Malar J (2005) 1.10
Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries. Epidemics (2011) 1.10
Transmission dynamics of hepatitis E among swine: potential impact upon human infection. BMC Vet Res (2007) 1.09
Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Trans R Soc Trop Med Hyg (2008) 1.09
How to find natural reservoir hosts from endemic prevalence in a multi-host population: a case study of influenza in waterfowl. Epidemics (2009) 1.08
The correlation between infectivity and incubation period of measles, estimated from households with two cases. J Theor Biol (2011) 1.08
Sentinel site community surveillance of mortality and nutritional status in southwestern Central African Republic, 2010. Popul Health Metr (2012) 1.08
The changing incidence of dengue haemorrhagic fever in Indonesia: a 45-year registry-based analysis. BMC Infect Dis (2014) 1.07
Early estimation of the reproduction number in the presence of imported cases: pandemic influenza H1N1-2009 in New Zealand. PLoS One (2011) 1.07